triiodothyronine has been researched along with Extrasystole, Ventricular in 2 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report the case of a 60 year old female patient on continuous systemic anticoagulation therapy with coumarin due to mechanical aortic valve replacement and a more than 3 years lasting amiodarone therapy due to severe ventricular extrasystoles suffering from amiodarone induced thyrotoxicosis (AIT)." | 7.74 | Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. ( Biersack, HJ; Brockmann, H; Bucerius, J; Ezziddin, S; Palmedo, H, 2007) |
| "We report the case of a 60 year old female patient on continuous systemic anticoagulation therapy with coumarin due to mechanical aortic valve replacement and a more than 3 years lasting amiodarone therapy due to severe ventricular extrasystoles suffering from amiodarone induced thyrotoxicosis (AIT)." | 3.74 | Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis. ( Biersack, HJ; Brockmann, H; Bucerius, J; Ezziddin, S; Palmedo, H, 2007) |
| "Patients with subclinical and treated overt hyperthyroidism have an excess vascular mortality rate." | 2.71 | Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment. ( Chowdhary, S; Daykin, J; Franklyn, JA; Gammage, MD; Holder, RL; Osman, F; Sheppard, MC, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Osman, F | 1 |
| Franklyn, JA | 1 |
| Daykin, J | 1 |
| Chowdhary, S | 1 |
| Holder, RL | 1 |
| Sheppard, MC | 1 |
| Gammage, MD | 1 |
| Bucerius, J | 1 |
| Ezziddin, S | 1 |
| Brockmann, H | 1 |
| Palmedo, H | 1 |
| Biersack, HJ | 1 |
1 trial available for triiodothyronine and Extrasystole, Ventricular
| Article | Year |
|---|---|
Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Autonomic Nervous System; Cohort Stu | 2004 |
1 other study available for triiodothyronine and Extrasystole, Ventricular
| Article | Year |
|---|---|
Impact of thyroid metabolism on the course of INR levels in a patient with systemic anticoagulation suffering from amiodarone-induced thyrotoxicosis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Coumarins; Female; Humans; International Normali | 2007 |